Stock Price Quote

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE700.05-11.4 (-1.6 %)
PREV CLOSE ( ) 711.45
OPEN PRICE ( ) 701.65
BID PRICE (QTY) 697.55 (15)
OFFER PRICE (QTY) 698.75 (1)
VOLUME 66075
TODAY'S LOW / HIGH ( )687.60 721.15
52 WK LOW / HIGH ( )625.6 863.15
NSE699.25-11.3 (-1.59 %)
PREV CLOSE( ) 710.55
OPEN PRICE ( ) 709.50
BID PRICE (QTY) 698.50 (2)
OFFER PRICE (QTY) 699.65 (4)
VOLUME 46872
TODAY'S LOW / HIGH( ) 691.00 721.40
52 WK LOW / HIGH ( )623.05 863
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 25-01 2007
Management Info
Amit Indubhushan Bakshi - Chairman Amit Indubhushan Bakshi - Managing Director
Registered Office

Address 8th Floor, Commerce House I V,Beside Shell Petrol Pump,100 Feet Road, Prahladnagar,
Ahmedabad,
Gujarat-380015

Phone 079 30451000

Email complianceofficer@erislifesciences.com

Website www.eris.co.in

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

18May UPDATE ON ACQUISTION OF OAKNET HEALTH
We refer to our earlier intimation dated 04th May, 2022, for acquisition..
18May Eris Lifesciences informs about corpor
Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligation..
05May Eris Lifesciences informs about audio
In accordance with the applicable requirements and regulations of the Se..
04May Eris Lifesciences informs about disclo
In accordance requirement of regulations 30 of the Securities and Exchan..
04May Eris Lifesciences acquires Oaknet Heal
Eris Lifesciences has acquired Mumbai-based dermatology-focused domestic..

Financials

in Millions
QTR Mar 22 ANNUAL 22
Net Profit867.094171.92
Gross Profit 946.29 4585.38
Operating Profit 1106.765129.84
Net Sales 2821.4212157.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE)
peergroup  4354.50 (1.88%)
M.Cap ( in Cr)72330.34
Shilpa Medicare (BSE)
peergroup  456.85 (11.35%)
M.Cap ( in Cr)3983.34
Hester Biosciences (BSE)
peergroup  2269.65 (1.65%)
M.Cap ( in Cr)1926.76
Hikal (BSE)
peergroup  403.55 (9.90%)
M.Cap ( in Cr)4906.14
Kwality Pharma (BSE)
peergroup  417.10 (5.00%)
M.Cap ( in Cr)432.79

Shareholding Pattern

PROMOTERS 52.66%
NON-INSTITUTION 23.52%
MUTUAL FUNDS/UTI 10.11%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Eris Lifesciences Ltd.

Eris Lifesciences Ltd. was incorporated in the year 2007. Its today's share price is 700.05. Its current market capitalisation stands at Rs 9417.81 Cr. In the latest quarter, company has reported Gross Sales of Rs. 11088.34 Cr and Total Income of Rs.11188.32 Cr. The company's management includes Amit Indubhushan Bakshi, Amit Indubhushan Bakshi, Milind Talegaonkar, Rajeev Dalal, Prashant Gupta, Kalpana Unadkat, Vijaya Sampath, Kaushal Shah, Inderjeet Singh Negi, Krishnakumar Vaidyanathan.

It is listed on the BSE with a BSE Code of 540596 , NSE with an NSE Symbol of ERIS and ISIN of INE406M01024. It's Registered office is at 8th Floor, Commerce House I V,Beside Shell Petrol Pump,100 Feet Road, PrahladnagarAhmedabad-380015, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells LLP, RR Shah & Associate

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)